It was observed that in the individual analysis of the molecular subtypes, in the triple negative and HER2-enriched, there were the highest rates of metastasis at diagnosis and, although it did not present statistical significance (p = 0.30), this data is in agreement with other studies,5, 33where these two subtypes were found among the most frequent metastatic disease. Here, ERBB2 is linked to metastatic neoplasm.